[HTML][HTML] Real-time mass spectrometric identification of metabolites characteristic of chronic obstructive pulmonary disease in exhaled breath

L Bregy, Y Nussbaumer-Ochsner, PML Sinues… - Clinical Mass …, 2018 - Elsevier
Background New mass spectrometry (MS) techniques analysing exhaled breath have the
potential to better define airway diseases. Here, we present our work to profile the volatile …

Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD

N Fens, SB de Nijs, S Peters, T Dekker… - European …, 2011 - Eur Respiratory Soc
Eosinophilic inflammation in chronic obstructive pulmonary disease (COPD) is predictive for
responses to inhaled steroids. We hypothesised that the inflammatory subtype in mild and …

Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho

T Oga, K Chin, M Mishima - European Respiratory Journal, 2014 - Eur Respiratory Soc
Forced expiratory volume in 1 s (FEV1) as a degree of airflow limit2ation has traditionally
been regarded as a crucial predictor of mortality in patients with chronic obstructive …

[HTML][HTML] 慢性阻塞性肺疾病多组学的研究成果汇报及展望

杨哲, 多杰 - Advances in Clinical Medicine, 2023 - hanspub.org
慢性阻塞性肺病(COPD) 是一种常见的异质性呼吸道疾病, 其特征是持续性和不完全可逆的气流
受限. 由于COPD 的异质性和表型复杂性, 传统的诊断方法只能提供有限的预测结果和治疗信息 …

[引用][C] 慢性阻塞性肺疾病的流行病学研究现状

乔翠霞, 李素云 - 中国老年学杂志, 2010 - cqvip.com
慢性阻塞性肺疾病(COPD) 是以不完全气流受限呈进行性发展为特征的一种可以预防和治疗的
疾病. 肺功能测定是诊断COPD 的金标准, 吸人支气管舒张剂后第一秒用力呼吸量(FEV1)< 80 …

[HTML][HTML] Serum metabolite biomarkers discriminate healthy smokers from COPD smokers

Q Chen, RS Deeb, Y Ma, MR Staudt, RG Crystal… - PloS one, 2015 - journals.plos.org
COPD (chronic obstructive pulmonary disease) is defined by a fixed expiratory airflow
obstruction associated with disordered airways and alveolar destruction. COPD is caused by …

[HTML][HTML] Bronchoalveolar lavage fluid from COPD patients reveals more compounds associated with disease than matched plasma

E Halper-Stromberg, L Gillenwater… - Metabolites, 2019 - mdpi.com
Smoking causes chronic obstructive pulmonary disease (COPD). Though recent studies
identified a COPD metabolomic signature in blood, no large studies examine the …

深入研究慢性阻塞性肺疾病的气道病变

赵鸣武 - 中华内科杂志, 1997 - cqvip.com
深入研究慢性阻塞性肺疾病的气道病变-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车
充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 学者空间 | 学术 …

Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases

W Ibrahim, L Carr, R Cordell, MJ Wilde, D Salman… - Thorax, 2021 - thorax.bmj.com
Exhaled breath analysis has the potential to provide valuable insight on the status of various
metabolic pathways taking place in the lungs locally and other vital organs, via systemic …

慢性阻塞性肺疾病发病因素的研究进展

赵玲珑, 肖玉艳 - 广东医学, 2006 - cqvip.com
慢性阻塞性肺疾病(COPD) 是危害人民健康的常见病, 在过去的几十年里, 其发病呈上升趋势,
越来越受到国内外医学专家的广泛关注和重视. COPD 是以不完全可逆性 …